Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
REGN on Nasdaq
Michael S. Brown - trading volume in the past year for Regeneron Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
6.16K |
$6.41M |
$1,040.00 |
Jun 14, 2024 |
by Trust |
|
|
Common Stock |
5K |
$5.2M |
$1,040.00 |
Jun 14, 2024 |
by SLAT |
|
|
Common Stock |
1.38K |
$1.44M |
$1,040.00 |
Jun 14, 2024 |
Direct |
|
|
Non-Qualified Stock Option (right to buy) |
0 |
|
|
Jun 14, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.